07/08/2018 Thought Leadership 23andNOTme 23andNOTme It’s almost been two weeks since GSK made a $300 million equity investment in personal genomics and biotech company 23andMe. And let’s just say the feedback has been...
09/03/2018 Culture Explaining the (NEW) gap between Indigo and Medical Explaining the (NEW) gap between Indigo and Medical By far the most controversial component of our re-brand It’s funny how change comes about. During our re-branding exercise we left...